Fundraising FoxAILA Biotech
Cambridge, GB · 1 known investors
Find your way into AILA Biotech
Sign up to see every warm intro you have to AILA Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AILA Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aila Biotech develops brain-targeted AAV gene therapy that enables the central nervous system to locally produce immune-modulating biologics, aiming to reduce chronic neuroinflammation while limiting systemic exposure. Its lead programme, AILA-001, targets primary progressive multiple sclerosis with potential expansion to other CNS inflammatory indications.
Founders & leadership
JD
James DooleyCEO & Co-founder
AL
Adrian ListonCSO & Co-founder
MH
Matthew HoltCo-founder & Head of Scientific Advisory Board
Investors · 1
Frequently asked questions
- What does AILA Biotech do?
- Aila Biotech develops brain-targeted AAV gene therapy that enables the central nervous system to locally produce immune-modulating biologics, aiming to reduce chronic neuroinflammation while limiting systemic exposure. Its lead programme, AILA-001, targets primary progressive multiple sclerosis with potential expansion to other CNS inflammatory indications.
- Who are AILA Biotech's investors?
- AILA Biotech's investors include University of Cambridge Enterprise.
- Where is AILA Biotech headquartered?
- AILA Biotech is headquartered in Cambridge, GB.